OncoMatch/Clinical Trials/NCT07628634
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Is NCT07628634 recruiting? Yes, currently enrolling (Jul 2026). This Early Phase 1 trial studies non-drug interventions for adenocarcinoma.
This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will receive systemic standard of care cancer therapy.
Check if I qualifyExtracted eligibility criteria
Cancer type
Tumor Agnostic
Urothelial Carcinoma
Osteosarcoma
Sarcoma
Rhabdomyosarcoma
Melanoma
Testicular Germ Cell Tumor
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Primary Central Nervous System Lymphoma
Glioblastoma
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Lab requirements
Blood counts
adequate organ function, as determined by the investigator through review of standard labs
Kidney function
adequate organ function, as determined by the investigator through review of standard labs
Liver function
adequate organ function, as determined by the investigator through review of standard labs
Subjects must have adequate organ function, as determined by the investigator through review of standard labs.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Chao Family Comprehensive Cancer Center, University of California, Irvine · Orange, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07628634 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages